David A. Pierce - 17 Feb 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP Pres MedSurg
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 17 Feb 2022
Net transactions value: -$176,229
Form type: 4
Filing time: 22 Feb 2022, 15:46:51 UTC
Previous filing: 17 Feb 2022
Next filing: 23 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+3,333		$0.000000	3,333	17 Feb 2022	Direct	F1
transaction	BSX	Common Stock	Tax liability	$41,931	-979	-29%	$42.83	2,354	17 Feb 2022	Direct
transaction	BSX	Common Stock	Options Exercise	$0	+2,668	+113%	$0.000000	5,022	18 Feb 2022	Direct	F2
transaction	BSX	Common Stock	Tax liability	$33,359	-784	-16%	$42.55	4,238	18 Feb 2022	Direct
transaction	BSX	Common Stock	Sale	$100,940	-2,354	-56%	$42.88	1,884	18 Feb 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Restricted Stock Units	Options Exercise	$0	-3,333	-25%	$0.000000	10,000	17 Feb 2022	Common Stock	3,333		Direct	F1, F4
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-2,668	-33%	$0.000000	5,337	18 Feb 2022	Common Stock	2,668		Direct	F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-l trading plan.
F4	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F5	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.